Vericel
VCEL • NASDAQ
Vericel is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dominick C. Colangelo, with a market cap of $1.7B.
Market Cap$1.7B
Employees314.0
CEODominick C. Colangelo
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Vericel FAQ
Common questions about Vericel
Vericel is scheduled to report earnings for Q1 2026 on May 14, 2026 before market open. Analysts estimate revenue of $63.7M.
Vericel has approximately 314 employees.